Can Better Diagnostics Lead to Improved Treatment for Cardiovascular Diseases?
- PlaqueTec
- Jan 23
- 1 min read
Published in Today’s Clinical Lab, Dr Simon Williams, General Manager at PlaqueTec, highlights a need to better characterise, risk stratify, and treat individual patients with coronary artery disease (CAD) to reduce the significant residual risk that remains from current, largely population-based approaches.
In this article, Simon explores the available technology used to diagnose and characterise CAD, including novel approaches to detect coronary inflammation, a known driver of atherosclerosis, and how combining these state-of-the-art diagnostic technologies holds huge potential to inform the development of precision medicines in CAD.
